FIRSTMARK CORP /ME/
SC 13D/A, 1997-05-12
FINANCE SERVICES
Previous: FIRSTMARK CORP /ME/, SC 13D/A, 1997-05-12
Next: CHART HOUSE ENTERPRISES INC, 10-Q, 1997-05-12





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                                 (Rule 13d-101)

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 1)1

                                 FIRSTMARK CORP.
    ---------------------------------------------------------------------------
                                (Name of Issuer)

                     Common Stock, Par Value $0.20 Per Share
    ---------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   337908 20 6
    ---------------------------------------------------------------------------
                                 (CUSIP Number)

                       Susan C. Coogan, 4712 Charmian Road
                            Richmond, Virginia 23226
    ---------------------------------------------------------------------------
       (Name, Address and Telephone Number of Person Authorized to Receive
                          Notices and Communications)

                                       N/A
    ---------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

             If the filing person has  previously  filed a statement on Schedule
    13G to report the acquisition which is the subject of this Schedule 13D, and
    is filing  this  schedule  because  of Rule  13d-1(b)(3)  or (4),  check the
    following box |_|.

             Note:  Six copies of this  statement,  including  all exhibits, 
    should be filed with the  Commission.  See Rule 13d-1(a) for other parties 
    to whom copies are to be sent.


                         (Continued on following pages)

                               (Page 1 of 7 Pages)




             1The  remainder  of this  cover  page  shall  be  filled  out for a
    reporting  person's  initial filing on this form with respect to the subject
    class of securities, and for any subsequent amendment containing information
    which would alter disclosures provided in a prior cover page.

             The information  required on the remainder of this cover page shall
    not be deemed to be "filed" for the purpose of Section 18 of the  Securities
    Exchange Act of 1934,  as amended (the "Act"),  or otherwise  subject to the
    liabilities  of that  section  of the Act but shall be  subject to all other
    provisions of the Act (however, see the Notes).


<PAGE>



    -----------------------------                       -----------------------
       CUSIP No. 337908 20 6           SCHEDULE 13D          Page 2 of 7 Pages
    -----------------------------                       -----------------------

    ------- -------------------------------------------------------------------
    1       NAME OF REPORTING PERSONS
            S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

            H. William Coogan Irrevocable Trust
    ------- -------------------------------------------------------------------
    2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*        (a)   [__]
                                                                     (b)   [__]
            Not Applicable                                                     
    ------- -------------------------------------------------------------------
    3       SEC USE ONLY


    ------- -------------------------------------------------------------------
    4       SOURCE OF FUNDS*

            OO
    ------- -------------------------------------------------------------------
    5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT 
            TO ITEM 2(d) or 2(e)
                                                                           [__]

            Not Applicable
    ------- -------------------------------------------------------------------
    6       CITIZENSHIP OR PLACE OF ORGANIZATION

            U.S.A.
    ----------------------- ------- -------------------------------------------
          NUMBER OF         7       SOLE VOTING POWER

            SHARES                  1,162,903**
                            ------- -------------------------------------------
                            8       SHARED VOTING POWER
         BENEFICIALLY
                                    -0-
                            ------- -------------------------------------------
        OWNED BY EACH       9       SOLE DISPOSITIVE POWER

          REPORTING                 1,162,903**
                            ------- -------------------------------------------
                            10      SHARED DISPOSITIVE POWER
         PERSON WITH
                                    -0-
    ----------------------- ------- -------------------------------------------
    11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

            1,162,903**
    ------- -------------------------------------------------------------------
    12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN 
            SHARES*                                                        [__]

            Not Applicable
    ------- -------------------------------------------------------------------
    13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

            21.9%**
    ------- -------------------------------------------------------------------
    14      TYPE OF REPORTING PERSON*

            OO (trust)
    ------- -------------------------------------------------------------------

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

**   See Item 3 below.


<PAGE>



    ---------------------------                          ----------------------
      CUSIP No. 337908 20 6            SCHEDULE 13D          Page 3 of 7 Pages
    ---------------------------                          ----------------------

    ------- -------------------------------------------------------------------
    1       NAME OF REPORTING PERSONS
            S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

            Susan C. Coogan
    ------- -------------------------------------------------------------------
    2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*        (a)   [__]
                                                                     (b)   [__]
            Not Applicable                                                     
    ------- -------------------------------------------------------------------
    3       SEC USE ONLY


    ------- -------------------------------------------------------------------
    4       SOURCE OF FUNDS*

            OO
    ------- -------------------------------------------------------------------
    5       CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
            TO ITEM 2(d) or 2(e)
                                                                           [__]

            Not Applicable
    ------- -------------------------------------------------------------------
    6       CITIZENSHIP OR PLACE OF ORGANIZATION

            U.S.A.
    ----------------------- ------- -------------------------------------------
          NUMBER OF         7       SOLE VOTING POWER

            SHARES                  1,162,903**
                            ------- -------------------------------------------
                            8       SHARED VOTING POWER
         BENEFICIALLY
                                    -0-
                            ------- -------------------------------------------
        OWNED BY EACH       9       SOLE DISPOSITIVE POWER

          REPORTING                 1,162,903**
                            ------- -------------------------------------------
                            10      SHARED DISPOSITIVE POWER
         PERSON WITH
                                    -0-
    ----------------------- ------- -------------------------------------------
    11      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

            1,162,903**
    ------- -------------------------------------------------------------------
    12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN 
            SHARES*
                                                                           [__]
            Not Applicable
    ------- -------------------------------------------------------------------
    13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

            21.9%**
    ------- -------------------------------------------------------------------
    14      TYPE OF REPORTING PERSON*

            IN
    ------- -------------------------------------------------------------------

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

**   See Item 3 below.


<PAGE>

         This  Amendment No. 1 hereby amends and supplements the Joint Schedule
13D (the "Joint  Schedule  13D") dated April 12,  1997,  filed by The H. William
Coogan  Irrevocable  Trust and Susan C. Coogan with the  Securities and Exchange
Commission (the "SEC") on or about April 14, 1997.


Item 1.           Security and Issuer.

                  This Joint Schedule 13D relates to the Common Stock, par value
$0.20 per share ("Common  Stock"),  of Firstmark Corp.  (the "Issuer"),  a Maine
corporation  that,  through a subsidiary,  Southern Title Insurance  Corporation
("STIC"), is principally engaged in the business of issuing title insurance. The
Issuer also makes venture  capital and real estate  investments.  The address of
the  principal  executive  offices of the  Issuer is One  Financial  Place,  222
Kennedy Memorial Drive, Waterville, Maine 04901.


Item 2.           Identity and Background.

                  H. William Coogan Irrevocable Trust

                  The H. William  Coogan  Irrevocable  Trust (the  "Trust") is a
trust organized under the laws of the  Commonwealth of Virginia.  The trustee of
the Trust is Susan C. Coogan. The Trust's principal business is investing in and
holding  stock and other  assets.  The address for the Trust is Susan C. Coogan,
Trustee,  4712 Charmian Road,  Richmond,  Virginia  23226.  During the past five
years,  the Trust has not been  convicted  in a criminal  proceeding,  excluding
traffic violations or similar misdemeanors,  nor has the Trust been a party to a
civil proceeding of a judicial or administrative body of competent  jurisdiction
or been subject to a judgment, decree or final order enjoining future violations
of,  or  prohibiting  or  mandating  activities  subject  to,  federal  or state
securities laws or finding any violation with respect to such laws.

                  Susan C. Coogan

                  (a)      Susan C. Coogan.

                  (b)      The address of Ms. Coogan is 4712 Charmian Road, 
Richmond, Virginia  23226.

                  (c)      Ms.  Coogan is employed as the Donor Services Officer
for The  Community  Foundation  Serving  Richmond  and Central  Virginia,  whose
address is 1025 Boulders Parkway, Suite 405, Richmond, Virginia 23225.

                  (d)      During  the  past  five  years,  Ms. Coogan  has not
been convicted in a criminal proceeding, excluding traffic violations or similar
misdemeanors.

                               Page 4 of 7 Pages
<PAGE>

                  (e)      During  the past five  years,  Ms. Coogan has not
been a party to a civil  proceeding  of a  judicial  or  administrative  body of
competent  jurisdiction and has not been subject to a judgment,  decree or final
order  enjoining  future  violations of, or prohibiting or mandating  activities
subject  to,  federal or state  securities  laws or finding any  violation  with
respect to such laws.

                  (f)      Ms. Coogan is a citizen of the United States of 
America.

Item 3.           Source and Amount of Funds or Other Consideration.

                  The source and amount of funds or other  consideration used by
the Trust and Ms.  Coogan,  as trustee,  in  acquiring  beneficial  ownership of
shares of Common Stock are as follows:

                  Prior to June 7, 1996, the Trust,  Donald V.  Cruickshanks and
H. William Coogan,  Jr. were the  shareholders of Southern  Capital  Corporation
("SCC").  SCC,  through its  subsidiary,  STIC,  is  principally  engaged in the
business of issuing title  insurance.  SCC also makes  venture  capital and real
estate  investments.  Between June 1992 and June 7, 1996, the Trust had acquired
36 shares of SCC common stock with trust funds.

                  On June 7, 1996, SCC was merged with and into Southern Capital
Acquisition  Corporation,  a Virginia corporation and wholly-owned subsidiary of
the Issuer ("SCAC"), pursuant to an Agreement and Plan of Reorganization,  dated
as of April 30, 1996,  between SCC, SCAC and the Issuer (the  "Reorganization").
As part of the Reorganization, each share of SCC common stock was converted into
and exchanged for 400 shares of the Issuer's  Series B,  cumulative,  non-voting
preferred  stock,  par value  $0.20  per share  ("Series  B  Preferred  Stock").
Accordingly,  the three  shareholders  of SCC received in the  aggregate  40,000
shares of Series B Preferred  Stock.  Pursuant to the  Statement  of  Resolution
Establishing  Series of Shares of the Issuer,  dated May 7, 1996 (the  "Series B
Resolution"), the shares of Series B Preferred Stock were not convertible by its
holders,  but were convertible by the Issuer into not less than 2,000,000 shares
of Common  Stock,  subject to adjustment if the market price of Common Stock was
less than $4.00 per share at the time of conversion. A more complete description
of the  Reorganization  is contained in the Issuer's  definitive Proxy Statement
for a Special Meeting of Stockholders held on February 25, 1997, which was filed
with the  Securities  and  Exchange  Commission  on February 5, 1997.  The Trust
acquired 14,400 shares of Series B Preferred Stock in the Reorganization.

                  In March 1997, the Issuer's Board of Directors approved of and
directed  the  conversion  of each  issued  and  outstanding  share of  Series B
Preferred Stock into shares of Common Stock,  effective April 1997,  pursuant to
the  Series B  Resolution.  Pursuant  to the  terms of the  Series B  Resolution
relating to the  determination  of the number of shares of Common Stock that the
holders of Series B Preferred  Stock shall  receive upon such  conversion,  each
share of Series B Preferred  Stock is convertible  into 80.7571 shares of Common
Stock.  Accordingly,  upon the  consummation of the  conversion,  the Trust will
receive 1,162,903 shares of Common Stock.

                  The  conversion  and the actual  issuance  of shares of Common
Stock to the Trust has not yet  occurred  and is  pending  the  approval  of the
Federal  Communications  Commission (the 


                               Page 5 of 7 Pages
<PAGE>

"FCC").  The Issuer  currently  owns the voting  stock of Champion  Broadcasting
Corporation  ("CBC"),  which owns and  operates  radio  stations  subject to FCC
regulation.  FCC  counsel  to  CBC  has  advised  the  Issuer  that  the  actual
acquisition by the Trust, and Ms. Coogan as trustee, of beneficial  ownership of
Common Stock cannot occur until the Issuer receives the necessary  approval from
the FCC or other  arrangements  are made with respect to the voting stock of CBC
that would obviate the need for such FCC approval.

                  Upon the conversion described above, the Trust and Ms. Coogan,
as trustee,  will acquire  beneficial  ownership  of 1,162,903  shares of Common
Stock.

                  Donald V.  Cruickshanks  is filing a separate Amendment  No. 1
to  Schedule  13D  with  respect  to  1,065,994  shares  of  Common  Stock to be
beneficially  owned by him,  and H.  William  Coogan,  Jr. is filing a  separate
Amendment No. 1 to Schedule 13D with respect to 1,001,389 shares of Common Stock
to be beneficially owned by him.


Item 4.           Purpose of Transaction.

                  The Trust's and Ms. Coogan's purpose in acquiring Common Stock
of the Issuer is described in Item 3 above.

                  There are no plans or proposals  that the Trust or Ms.  Coogan
may have that relate to or would result in:

                  (a)      the  acquisition by any person of additional
                  securities of the Issuer, or the disposition of securities of
                  the Issuer;

                  (b)      an extraordinary  corporate  transaction,  such as a
                  merger,  reorganization  or liquidation, involving  the Issuer
                  or any of its subsidiaries;

                  (c)      a sale or transfer  of a material amount of assets of
                  the Issuer of any of its subsidiaries;

                  (d)      any change in the present  board of  directors or
                  management  of the Issuer,  including  any plans or  proposals
                  that  change  the number or term of  directors  or to fill any
                  existing vacancies on the board;

                  (e)      any material  change in the present capitalization or
                  dividend  policy of the  Issuer;

                  (f)      any other material change in the Issuer's business or
                  corporate structure;

                  (g)      changes in the Issuer's charter, bylaws or 
                  instruments corresponding thereto or other actions that may 
                  impede the acquisition of control of the Issuer by any person;


                               Page 6 of 7 Pages
<PAGE>

                  (h)      causing a class of securities of the Issuer to be
                  delisted from a national securities exchange or to cease to be
                  authorized to be quoted in an inter-dealer quotation system of
                  a registered national securities association;

                  (i)      a class of equity  securities of the Issuer  becoming
                  eligible for  termination of registration  pursuant to Section
                  12(g)(4) of the Securities Exchange Act of 1934, as amended; 
                  or

                  (j)      any action similar to any of those enumerated above.


Item 5.           Interest in Securities of the Issuer.

                  (a)      Subject to the regulatory approval described  in Item
3 above,  the aggregate number and percentage of Common Stock to be beneficially
owned by the Trust will be  1,162,903  and 21.9% of the  issued and  outstanding
shares of Common Stock,  and the aggregate number and percentage of Common Stock
to be beneficially owned by Ms. Coogan, as trustee,  will be 1,162,903 and 21.9%
of the issued and outstanding shares of Common Stock.

                  (b)      Subject to the  regulatory  approval  described  in 
Item 3 above,  the Trust will  possess the sole power to vote or direct the vote
and to dispose or direct the  disposition  of 1,162,903  shares of Common Stock,
and Ms.  Coogan,  as trustee,  will possess the sole power to vote or direct the
vote and to dispose  or direct the  disposition  of  1,162,903  shares of Common
Stock.

                  (c)      On March 12, 1997, the Issuer approved of and 
directed  the  conversion  of each  issued  and  outstanding  share of  Series B
Preferred  Stock into shares of Common Stock,  effective  April 1997.  Under the
terms of the Series B Preferred  Stock,  each share of Series B Preferred  Stock
will be  convertible  into 80.7571  shares of Common Stock.  For a more complete
description of this and related transactions, see Item 3 above.

                  (d)      Not applicable.

                  (e)      Not applicable.


Item 6.           Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.

                  Ms. Coogan is a director of the Issuer.


Item 7.           Material to be Filed as Exhibits.

                  See Exhibit Index.



                               Page 7 of 7 Pages
<PAGE>



                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and belief, we
certify that the information  set forth in this statement is true,  complete and
correct.





Date:  May 9, 1997                       /s/ Susan C. Coogan
                                         --------------------------------------
                                         Susan C. Coogan




                                         H. WILLIAM COOGAN
                                         IRREVOCABLE TRUST



Date:  May 9, 1997                       /s/ Susan C. Coogan, Trustee
                                         --------------------------------------
                                         By: Susan C. Coogan, Trustee







Attention:  Intentional misstatements or omissions of fact constitute federal
            criminal violations (see 18 U.S.C. 1001).





<PAGE>




                                  Exhibit Index

Exhibit           Description

A.                Agreement to Joint Filing of Schedule 13D.




<PAGE>


                                                                       Exhibit A

                            AGREEMENT TO JOINT FILING
                        OF AMENDMENT NO.1 TO SCHEDULE 13D
                               DATED MAY 12, 1997


         Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934,
as amended, we agree that this Schedule 13D is filed on behalf of each of us.





Date:  May 9, 1997                       /s/ Susan C. Coogan
                                         --------------------------------------
                                         Susan C. Coogan




                                         H. WILLIAM COOGAN
                                         IRREVOCABLE TRUST



Date:  May 9, 1997                       /s/ Susan C. Coogan, Trustee
                                         --------------------------------------
                                         By: Susan C. Coogan, Trustee






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission